Abstract
Elevated systolic BP (SBP) is a major contributor to cardiovascular disease. SBP control reduces the occurrence of stroke, heart failure, and cardiovascular and total mortality. The aim of this study was to analyze the magnitude of SBP reductions and the achievement of individual SBP targets in the original BENIFORCE study. An olmesartan medoxomil-based treatment algorithm was evaluated in a double-blind, placebo-controlled titration study in 276 patients with stage 1 (47.1%) or 2 (52.9%) hypertension. After placebo run-in, patients were randomized to placebo (12 weeks) or olmesartan medoxomil 20 mg/day (weeks 1-3). Olmesartan medoxomil was uptitrated to 40 mg/day (weeks 4-6), then olmesartan medoxomil/hydrochlorothiazide (HCTZ) 40/12.5 mg per day (weeks 7-9), and olmesartan medoxomil/HCTZ 40/25 mg per day (weeks 10-12) if BP remained ≥120/80 mmHg at any time interval. The BENIFORCE study was a multicenter (29 sites) study conducted between January and October 2007 in the US. In patients receiving olmesartan medoxomil-based therapy, 81.0%, 67.2%, and 46.6% of patients with stage 1 hypertension and 70.4%, 49.4%, and 23.5% of patients with stage 2 hypertension achieved SBP targets of <140, <130, and <120 mmHg, respectively (all p...Continue Reading
References
Jul 1, 1995·Hypertension·M O'Rourke
Mar 1, 1995·Hypertension·V L BurtD Labarthe
Jul 1, 1997·Circulation·S S FranklinD Levy
Jun 17, 1999·Archives of Internal Medicine·C AlliG Tognoni
Mar 10, 2001·Circulation·S S FranklinD Levy
Aug 13, 2002·Journal of Hypertension·Giuseppe Mancia, Guido Grassi
Dec 21, 2002·Lancet·Sarah LewingtonUNKNOWN Prospective Studies Collaboration
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jun 23, 2004·Lancet·Stevo JuliusUNKNOWN VALUE trial group
May 25, 2005·Hypertension·Michael F O'Rourke, Michel E Safar
Jan 25, 2006·Hypertension·Eni C OkonofuaBrent M Egan
Sep 1, 2006·American Journal of Hypertension·Bernard Waeber, Jean-Jacques Mourad
Sep 20, 2006·Hypertension·Jun MaRandall S Stafford
Dec 5, 2006·Journal of Hypertension·Minoru YambeAkira Yamashina
Jan 12, 2007·The Journal of Clinical Hypertension·Joseph L IzzoFindlay Walker
Jul 4, 2007·Hypertension·Giuseppe ManciaCarl J Pepine
Dec 19, 2007·Circulation·Wayne RosamondUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Jun 20, 2008·Lancet·Bryan WilliamsPeter Sever
Jul 16, 2008·Archives of Internal Medicine·Erik IngelssonDaniel Levy
Jan 6, 2009·The Journal of Clinical Hypertension·Suzanne OparilRobert Dubiel
Aug 18, 2009·Lancet·Paolo VerdecchiaUNKNOWN Cardio-Sis investigators
Mar 17, 2010·The New England Journal of Medicine·William C CushmanFaramarz Ismail-Beigi